Summary:
- This article discusses a new platform that can improve the prediction of how the human body will respond to antibody-based drugs.
- The platform uses machine learning to analyze data on the structure and properties of antibodies, as well as how they interact with their targets, to better predict their effectiveness and potential side effects.
- This improved prediction capability could help in the development of more effective and safer antibody-based therapies for a variety of diseases.